The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Nichols William Garrett since 2020.
This trader's CIK number is 1618364.
At the time of last reporting, Nichols William Garrett was the Chief Medical Officer of Candel Therapeutics, Inc.. (stock ticker symbol CADL).
Also see all insider trading activities at Candel Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | CADL | 0 | $0 | 68,261 | $571,577 | 20,207 | $48,807 |
| 2024 | CADL | 0 | $0 | 34,579 | $192,230 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | CMRX | 0 | $0 | 42,035 | $85,216 | 0 | $0 |
1. Candel Therapeutics, Inc. (CADL)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-28 | CADL | Option Ex | 937 | 1.29 | 1,208 |
| 2025-07-28 | CADL | Sale | 937 | 6.98 | 6,540 |
| 2025-06-30 | CADL | Option Ex | 781 | 1.29 | 1,007 |
| 2025-06-30 | CADL | Sale | 781 | 5.04 | 3,936 |
| 2025-03-18 | CADL | Option Ex | 18,489 | 2.52 | 46,592 |
| 2025-03-18 | CADL | Sale | 45,316 | 8.76 | 397,013 |
| 2025-01-15 | CADL | Sale | 10,428 | 7.22 | 75,342 |
| 2025-01-08 | CADL | Sale | 10,799 | 8.22 | 88,746 |
| 2024-11-29 | CADL | Sale | 13,935 | 4.56 | 63,487 |
| 2024-07-17 | CADL | Sale | 10,875 | 6.47 | 70,393 |
| 2024-07-11 | CADL | Sale | 9,769 | 5.97 | 58,350 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-02-07 | CMRX | Sale | 2,550 | 1.70 | 4,335 |
| 2020-02-10 | CMRX | Sale | 8,805 | 1.68 | 14,827 |
| 2020-01-07 | CMRX | Sale | 30,680 | 2.15 | 66,054 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Nichols William Garrett (Chief Medical Officer of Candel Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.